ARTICLE | Emerging Company Profile
Afyx: Mucosal drug delivery
How Afyx’s drug patches could replace topical agents for mucosal diseases
November 30, 2018 10:59 PM UTC
Afyx Therapeutics is developing bioadhesive patches for mucosal drug delivery to address diseases that are inadequately treated by topical agents.
Diseases affecting topically accessible mucosal sites, such as the buccal mucosa, are difficult to treat because mucosal secretions clear gel, cream and ointment formulations away from tissue, and adhesives generally do not stick well to wet surfaces. ...
BCIQ Company Profiles